The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.

Allison Portnoy Rebecca A Clark Matthew Quaife Chathika Krishan Weerasuriya Christinah Mukandavire Roel BakkerArminder K DeolShelly MalhotraNebiat GebreselassieMatteo ZignolSo Yoon SimRaymond C W HutubessyInés Garcia BaenaNobuyuki Nishikiori Mark Jit Richard G White Nicolas A Menzies

Published in: PLoS medicine (2023)

TB vaccination would be highly impactful and cost-effective in most LMICs. Further efforts are needed for future development, adoption, and implementation of novel TB vaccines.

Keyphrases

mycobacterium tuberculosis
quality improvement
primary care
healthcare
current status
hiv aids
emergency department
hiv infected
antiretroviral therapy